New York & Pittsburgh, PA – November 17, 2015 – RenovaCare, Inc. (OTCQB: RCAR), today announced a partnership to validate the science behind its groundbreaking technology for treatments of wounds, burns and other skin defects. The company’s research partner is Berlin-Brandenburg Center for Regenerative Therapies (BCRT), a translational research center at Charité – Universitätsmedizin Berlin,…
RenovaCare, Inc., (RCAR), developer of the patented CellMist™ and SkinGun™ technologies for isolating and spraying a patient’s own stem cells onto burns and wounds for rapid self-healing, today announced the appointment of healthcare executive and industry thought-leader, Michael M. Barch, to its Board of Advisors. Barch currently serves as Chairman of the Board of the…
Great ideas need great people to bring them to life. With this establishing principle, RenovaCare has assembled a highly skilled team of experienced managers and executives dedicated to advancing its CellMist™ System and related medical technologies. Since organizing as a medical device company, we have built a team with diverse backgrounds in commercial medical technology,…
The SkinGun™ is profiled on National Geographic. Click here to watch the video at natgeo.com (opens in a new tab or window). RenovaCare’s patented SkinGun™ spray device is the world’s most advanced technology of its kind. As part of our groundbreaking CellMist™ System, it has shown in early clinical observations in the United States and…
RenovaCare has joined forces with StemCell Systems GmbH, one of Germany’s leading firms in the field of technologies for regenerative medicine, to advance its CellMist™ System and SkinGun™ delivery device toward commercial release. StemCell Systems invents and engineers biomedical devices for regenerative medicine. Based in Berlin, Germany, their engineering services are geared toward providing innovation…